Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex. 2007

Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai, China.

Transcutaneous immunization presents a major challenge on account of poor permeability of antigens through the skin barrier. To overcome this limitation, the deformable liposome could be a better method for transcutaneous delivery of these antigens. In this study, hepatitis B surface antigen (HBsAg) plasmid DNA-cationic complex deformable liposome was utilized as a mode for enhanced immunity against the antigen. Deformable liposome was prepared by conventional rotary evaporation method and characterized for various parameters such as vesicles shape and surface morphology, size and size distribution, entrapment efficiency, elasticity and stability. The immune stimulating activity was studied by measuring serum anti-HBsAg titre and cytokines level (interleukin-4 and interferon-gamma) following topical application of liposome in BALB/c mice and results were compared with deformable liposome encapsulated DNA applied topically as well as naked DNA and pure recombinant HBsAg, administered intramuscularly. It was observed that deformable liposome elicited a comparable serum antibody titre and endogenous cytokines levels compared to other vaccinations. The study signifies the potential of deformable liposome as DNA vaccine carriers for effective transcutaneous immunization.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
September 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
December 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
October 2012, Viral immunology,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
July 2011, International journal of pharmaceutics,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
August 1987, American journal of reproductive immunology and microbiology : AJRIM,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
January 1999, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
January 2008, DNA and cell biology,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
January 2000, Intervirology,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
February 2010, Vaccine,
Jing Wang, and Jin-hong Hu, and Feng-qian Li, and Guan-zhong Liu, and Quan-gang Zhu, and Ji-yong Liu, and Hong-jun Ma, and Cheng Peng, and Fu-guo Si
February 2005, Vaccine,
Copied contents to your clipboard!